Advertisement
Screener

GENELUX CORPORATION (GNLX) P/E Ratio

2.8 / 5 stars · 68/120 Roast Me

GENELUX Corp PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • GENELUX Corp pe ratio for the quarter ending 2026-06-30 was -3.83, a change of -0.22 year-over-year.
  • GENELUX Corp pe ratio for the quarter ending 2026-03-31 was -3.22, a change of 0.23 year-over-year.
  • GENELUX Corp pe ratio for the quarter ending 2025-12-31 was -5.17, a change of -2.42 year-over-year.
  • GENELUX Corp pe ratio for the quarter ending 2025-09-30 was -5.03, a change of -2.07 year-over-year.
  • GENELUX Corp pe ratio for fiscal 2026 was -3.83.
  • GENELUX Corp pe ratio for fiscal 2025 was -5.17, a change of -2.42 from fiscal 2024.
  • GENELUX Corp pe ratio for fiscal 2024 was -2.74, a change of 10.52 from fiscal 2023.
  • GENELUX Corp pe ratio for fiscal 2023 was -13.26.
Available history
2023-03-31 to 2026-06-30
Data captured

Historical PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-3.83$136.21M-$35.6M
2026-03-31-3.22$108.07M-$33.58M
2025-12-31-5.17$166.1M-$32.15M
2025-09-30-5.03$160.18M-$31.87M
2025-06-30-3.6$109.5M-$30.39M
2025-03-31-3.45$101.88M-$29.51M
2024-12-31-2.74$81.96M-$29.87M
2024-09-30-2.96$81.86M-$27.66M
2024-06-30-2.54$67.3M-$26.54M
2024-03-31-6.73$173.59M-$25.78M
2023-12-31-13.26$375.31M-$28.3M
2023-09-30-26.09$652.85M-$25.03M
2023-06-30-57.27$845.99M-$14.77M
2023-03-31-57.87$681.11M-$11.77M

Annual PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-3.83$136.21M-$35.6M
2025-12-31-5.17$166.1M-$32.15M
2024-12-31-2.74$81.96M-$29.87M
2023-12-31-13.26$375.31M-$28.3M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
Equillium, Inc. (EQ)United States$0.109B-11.27
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ProMIS Neurosciences Inc. (PMN)$0.102B
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95